tiprankstipranks
MYUNGMOON Pharm Co., Ltd. (KR:017180)
:017180
South Korea Market
017180
MYUNGMOON Pharm Co., Ltd.
RESEARCH TOOLSreports

MYUNGMOON Pharm Co., Ltd. (017180) Financial Statements

― Followers

MYUNGMOON Pharm Co., Ltd. Financial Overview

MYUNGMOON Pharm Co., Ltd.'s market cap is currently ₩41.58B. The company's EPS TTM is ₩-60.35; its P/E ratio is -20.61; and it has a dividend yield of 1.67%. MYUNGMOON Pharm Co., Ltd. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 195.25B₩ 186.44B₩ 169.57B₩ 152.13B₩ 137.76B
Gross Profit₩ 107.19B₩ 104.97B₩ 95.35B₩ 78.10B₩ 62.34B
Operating Income₩ 6.83B₩ 1.93B₩ 963.77M₩ 6.43B₩ -5.88B
EBITDA₩ 10.13B₩ 5.67B₩ 4.53B₩ 10.57B₩ 345.37M
Net Income₩ 1.90B₩ -3.03B₩ -4.52B₩ 7.87B₩ -6.80B
Balance Sheet
Cash & Short-Term Investments₩ 6.15B₩ 4.76B₩ 11.66B₩ 9.98B₩ 10.52B
Total Assets₩ 272.46B₩ 257.99B₩ 236.55B₩ 230.45B₩ 223.26B
Total Debt₩ 98.63B₩ 87.51B₩ 90.48B₩ 83.16B₩ 84.13B
Net Debt₩ 92.80B₩ 83.11B₩ 82.52B₩ 78.30B₩ 77.32B
Total Liabilities₩ 168.00B₩ 154.87B₩ 147.79B₩ 135.18B₩ 137.39B
Stockholders' Equity₩ 98.74B₩ 96.85B₩ 83.45B₩ 89.52B₩ 80.26B
Cash Flow
Free Cash Flow₩ -8.46B₩ -2.74B₩ -8.17B₩ 3.53B₩ 480.28M
Operating Cash Flow₩ -1.70B₩ -1.34B₩ -5.18B₩ 5.47B₩ 855.00M
Investing Cash Flow₩ -7.20B₩ 967.90M₩ 1.82B₩ -4.93B₩ 9.08B
Financing Cash Flow₩ 10.32B₩ -3.22B₩ 6.45B₩ -2.50B₩ -7.68B
Currency in KRW

MYUNGMOON Pharm Co., Ltd. Earnings and Revenue History

Income Statement >

MYUNGMOON Pharm Co., Ltd. Debt to Assets

Balance Sheet >

MYUNGMOON Pharm Co., Ltd. Cash Flow

Cash Flow >

MYUNGMOON Pharm Co., Ltd. Forecast EPS vs Actual EPS

Earnings >